Audited Supplier
Newcastle Disease, Infectious Bursal and Avian Influenza (H9 Subtype) Vaccine, Inactivated (Strain La Sota + Strain BJQ902 + Strain WD)
Generic Name: Newcastle Disease, Infectious Bronchitis and Avian Influenza (H9 Subtype) Vaccine, Inactivated (Strain La Sota + Strain BJQ902 + Strain WD)
Commercial Name: Fayoubao
Main Component: The virus content per dose (0.5ml):
Inactivated Newcastle Disease Virus ≥108.2EID50/dose, H9 Subtype AIV Antigen ≥107.2EID50/dose, Infectious Bursal Virus ≥108.2TCID50/dose
Physical Property: The product is white homogeneous emulsion.
Indication and Effect: It is used for prevention of Avian Newcastle Disease, Infectious Bursal and H9 Avian Influenza. After vaccination, the immunity will be developed in 14-21 days. The immunization period is 2 months for chicks and 6 months for adult chickens.
Dosage and Administration: Subcutaneous at the neck or intramuscular injection. The dosage is 0.3 ml/bird for chicks younger than 4 weeks, and 0.5 ml/bird for the chickens older than 4 weeks.
Precaution:
1. It can be only vaccinated to healthy chickens.
2. The vaccine should be thoroughly shaken and be raised to room temperature before use.
3. The vaccinated chicks shall be isolated from other chickens with a reduced stocking density. And, try to avoid the fecal pollution to the drinking water and feedstuff.
4. The vaccine should be run out within one day after it has been opened.
5. The local disinfection treatment should be carry out when proceed the vaccination.
6. The used vaccine vials, tools and unpacked vaccines should be treated harmlessly.
7. For broilers, this vaccine was forbidden to use within 21 days before slaughter. For other chickens, forbid to use this vaccine within 42 days before slaughter.
Specification: 250ml/bottle
Package: 40 bottles/cartons
Storage and Shelf life: 12 months at the temperature of 2-8ºC.
Approval No.: Shou Yao Sheng Zi 010372300
Manufacturer: Beijing Sinder-vet Technology Co., Ltd.
A subsidiary of the Shandong Sinder Technology Co., Ltd
Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.
Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!
Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.
Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.
